Skip to main content
. 2022 Jun 17;122:553–558. doi: 10.1016/j.ijid.2022.06.016

Table 5.

Safety profile of the study arms.

Adverse event Combined therapy Single therapy Control group Overall P-value
N 59 56 57 172 -
Epigastralgia 7 (11.9%) 5 (8.9%) 2 (3.5%) 14 (8.1%) 0.249
Nausea 1 (1.7%) 6 (10.7%) 1 (1.8%) 8 (4.7%) 0.032
Overall 8 (13.6%) 11 (19.6%) 3 (5.3%) 22 (12.8%) 0.071

Values are presented as number (percentage).